Serum leptin changes in epileptic patients who gain weight after therapy with valproic acid.
about
Adverse effects of antiepileptic drugs.Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities.Adolescent issues in epilepsy.Polycystic ovary syndrome in women using valproate: a review.Leptin consumption in the inflamed joints of patients with rheumatoid arthritisPsychiatric medication induced obesity: an aetiologic review.Association of LEPR and ANKK1 Gene Polymorphisms with Weight Gain in Epilepsy Patients Receiving Valproic Acid.Preventive treatment of migraine: effect on weight.Search for common targets of lithium and valproic acid identifies novel epigenetic effects of lithium on the rat leptin receptor gene.Effect of valproic acid on body weight, food intake, physical activity and hormones: results of a randomized controlled trial.Weight gain following treatment with valproic acid: pathogenetic mechanisms and clinical implications.Weight change, genetics and antiepileptic drugs.Treating epilepsy in the setting of medical comorbidities.Antiepileptic drugs influences on body weight in people with epilepsy.Valproic acid and nonalcoholic fatty liver disease: A possible association?Serum Insulin and Leptin Levels in Children with Epilepsy on Valproate-associated Obesity.Chronic exposure to valproic acid promotes insulin release, reduces KATP channel current and does not affect Ca (2+) signaling in mouse islets.Weight gain and insulin resistance in children treated with valproate: the influence of time.The metabolic syndrome in overweight epileptic patients treated with valproic acid.Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls.Serum insulin and leptin levels in valproate-associated obesity.Insulin resistance in epileptic girls who gain weight after therapy with valproic acid.Serum insulin and leptin levels and valproate-associated obesity.Body mass index and serum lipid changes during treatment with valproic acid in children with epilepsy.Insulin resistance in patients on valproic acid: relation to adiponectin.Weight change in monozygotic twins treated with valproate.The role of ghrelin in weight gain and growth in epileptic children using valproate.Serum insulin, leptin, and neuropeptide y levels in epileptic children treated with valproate.Weight and fat distribution in patients taking valproate: a valproate-discordant gender-matched twin and sibling pair study.Plasma leptin, neuropeptide Y, ghrelin, and adiponectin levels and carotid artery intima media thickness in epileptic children treated with valproate.Valproate, bipolar disorder and polycystic ovarian syndrome.
P2860
Q33961524-FDEC5D70-EE94-41B3-A524-F25B65972EE6Q34230366-EC5B7494-1A8B-4B1B-B6E3-817643CBD4CAQ34599674-76EE69C6-3A18-4F9B-8B45-11D56BCBCAFFQ34881401-42CC84E2-DA0E-4673-8189-4346575AFDC7Q35552048-31195D93-C661-4D7C-9E7D-CE94A3B5EFB1Q35831682-CFE6E439-9C90-416D-833C-8857FF3A1C03Q35965897-C32D8299-C6FF-41C9-BAE8-A4C009045CA9Q35987931-82B8F5A7-C620-49B3-ABDC-3FF305AF2144Q37347610-B732CC98-C006-4680-8D0E-7928748A0E1CQ37366007-83EB781F-B2A3-4C76-A4FA-B5ACA96DFDD9Q37794213-014D3C66-BEE6-4EC7-9EDF-C7F300F16772Q38168942-48FC9DD5-DD81-4489-935F-C66A541FB29EQ38214818-4D150F79-2393-4849-BEDF-96616E891097Q38285318-19224257-C3A4-4DCC-A42F-0CE2BFBF0713Q38505408-5035DD5F-FF20-4029-9C1B-828ECE9727B9Q41593966-19374CD1-6866-476C-8FB9-F9976D39D25DQ42446162-BA36A7D6-857E-4962-A94A-AE5CA6F079DBQ43140659-63814133-BAE7-408F-8411-28420B8A27A1Q43291770-F55DCBBA-A7C3-4796-AFCF-17C3EC239627Q43996934-84240053-D3C9-447F-80FE-C504F45264D4Q44004469-629A3FAB-3BC6-41EC-8F04-76B8E9D6BD28Q44043948-48697ED7-59C6-4F3F-8286-38238F070F49Q44667902-44F3BB3B-7013-498B-A502-ADB695F87052Q46208501-817D07C7-BF2A-4C4D-8322-5574939883BDQ46601959-6553A245-9F75-4EB7-8675-248BFB6E03FAQ46675935-4272539F-4331-4216-A031-52C2C4126C5CQ46823814-A9EE914E-15DD-4B0B-AD0D-B5D0F00458BDQ46897650-7F514416-4A68-4516-91AE-B313A1BA0BC4Q47442417-8D19E629-F060-4114-AFBE-F196A3040487Q51356301-466CEDC7-F471-4D5A-A0CB-7A019BB4593BQ51537591-E6A145CD-85F2-4A7F-BFC0-86AC135D1CBF
P2860
Serum leptin changes in epileptic patients who gain weight after therapy with valproic acid.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Serum leptin changes in epilep ...... er therapy with valproic acid.
@en
Serum leptin changes in epilep ...... er therapy with valproic acid.
@nl
type
label
Serum leptin changes in epilep ...... er therapy with valproic acid.
@en
Serum leptin changes in epilep ...... er therapy with valproic acid.
@nl
prefLabel
Serum leptin changes in epilep ...... er therapy with valproic acid.
@en
Serum leptin changes in epilep ...... er therapy with valproic acid.
@nl
P2093
P356
P1433
P1476
Serum leptin changes in epilep ...... er therapy with valproic acid.
@en
P2093
Basciani F
Chiarelli F
Verrotti A
de Martino M
P304
P356
10.1212/WNL.53.1.230
P407
P577
1999-07-01T00:00:00Z